Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: salt lakes, sea and hypersaline soils
DNA G+C(%): 60.7-64
|
Lower T(℃): 25(+)
High T(℃): 45(+)
NaCl 0.5-2%: 0(neg)
NaCl >6%: 8(+)
pH 6.0-8.0: 6.0(+)
pH >8: 9(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: S(10; disc)
carbenicil: S(100; disc)
penicillin_G: S(10U)
|
cephalothin: S(30; disc)
|
amikacin: R(300; disc)
gentamicin: Var(MIC50): 10; disc), MIC90: Var(10; disc
streptomycin: Var(MIC50): 10; disc), MIC90: Var(10; disc
|
erythromycin: S(15; disc)
|
nalidixic-acid: S(15; disc)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Var(MIC50): 30; disc), MIC90: Var(30; disc
|
|
rifampicin: S(5; disc)
|
chloramphenicol: S(30; disc)
SXT: Var(MIC50): 25; disc), MIC90: Var(25; disc
|
clindamycin: R(2U)
colistin: S(50; disc)
polymyxin_B: S(300U)
|